학술논문
Impact of COVID‐19 in patients with autoimmune bullous diseases: Report from an international registry.
Document Type
Article
Author
Meijer, Joost M.; Rashid, Hanan; Vergadi, Styliani; Antiga, Emiliano; Vezzoli, Pamela; Balestri, Riccardo; Patsatsi, Aikaterini; Uzun, Soner; Skiljevic, Dusan; Jedlickova, Hana; Janickova, Lucia; Corrà, Alberto; Ponziani, Alessandra; Günther, Claudia; Cianchini, Giuseppe; Schefzyk, Matthias; Marzano, Angelo; Di Zenzo, Giovanni; Shimanovich, Iakov; Fairley, Janet
Source
Subject
*BULLOUS pemphigoid
*REPORTING of diseases
*COVID-19
*AUTOIMMUNE diseases
*MEDICAL personnel
*COVID-19 pandemic
*
*
*
*
*
Language
ISSN
0926-9959
Abstract
In summary, this international registry showed a rather stable disease activity in the majority of AIBD patients following COVID-19 infection. Death occurred in nine patients (13%) with a mean age of 84.3 years; 6 of the 9 patients (67%) of them died during hospitalization for COVID-19 infection. Respectively, the change in disease activity of AIBD before and after COVID-19 infection is shown in Figure 1d. 1 TABLE Reported systemic treatment for AIBD before and after COVID-19 infection. [Extracted from the article]